PATENT CLAIM ANALYSIS

Application Number: 16165940
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["435", "122000"]

Abstract:
Methods and engineered yeast cells for generating a benzylisoquinoline alkaloid product are provided herein. A method comprises providing engineered yeast cells and a feedstock to a reactor. In the reactor, the engineered yeast cells are subjected to fermentation by incubating the engineered yeast cells for a time period to produce a solution comprising the BIA product and cellular material. The solution comprises not more than one class of molecule selected from the group of protoberberine, morphinan, isopavine, aporphine, and benzylisoquinoline. Additionally, at least one separation unit is used to separate the BIA product from the cellular material to provide the product stream comprising the BIA product.

Claim (Index 34):
The method of  claim 31 , wherein the plurality of engineered non-plant cells comprises the plurality of bacterial cells.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 1.8871
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15031618', '16149025', '15078874', '14614484', '15139263']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6444527934898289
- 35 USC 102 Novelty (BERT): 0.5308897619720843
- Combined Prediction Score: 0.6330964903380544
- Mean Citation Score: 374.338764
- Max Citation Score: 467.9146
- Similarity Product: 307.0543419510365

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test